文献速递烧伤创面修复

耐甲氧西林金黄色葡萄球菌鼻腔拭子对烧伤ICU患者肺炎的预测价值

Predictive values of methicillin-resistant Staphylococcus aureus nasal swabs for pneumonia in burn ICU patients.
PubMed 文献 · Burns · 2024-09-02

本回顾性队列研究纳入2016至2021年某三级医疗中心烧伤ICU的18岁及以上烧伤患者,分析耐甲氧西林金黄色葡萄球菌(MRSA)鼻腔拭子对肺炎的预测价值。共136例患者发生267次肺炎,MRSA鼻腔拭子总体灵敏度39%、特异度98.7%、阳性预测值84.2%、阴性预测值89.9%。结论认为,抗菌药物启动后不足7天采集的阴性MRSA鼻腔拭子可用于临床稳定的疑似肺炎烧伤患者降阶梯抗MRSA治疗。

要点

  • MRSA鼻腔拭子总体灵敏度39%、特异度98.7%、PPV 84.2%、NPV 89.9%。
  • 抗菌药物启动后不足7天采集的拭子特异度98.6%、NPV 98.6%。
  • 抗菌药物启动后至少7天采集的拭子特异度98.7%、NPV 86.4%。

核心结论

  • 高特异度和NPV表明,抗菌药物启动后不足7天采集的阴性MRSA鼻腔拭子可用于临床稳定的疑似肺炎烧伤患者降阶梯抗MRSA治疗。
  • NPV下降提示定期重复采集拭子可能有益。

研究设计与样本

  • 回顾性队列研究,纳入2016至2021年某三级医疗中心烧伤ICU的18岁及以上烧伤患者,要求有肺炎ICD-10编码、入院期间采集MRSA鼻腔拭子、并有至少连续5天抗菌药物相关的呼吸道培养。
  • 共136例患者发生267次肺炎。

主要发现

  • MRSA鼻腔拭子总体灵敏度39%、特异度98.7%、PPV 84.2%、NPV 89.9%。
  • 抗菌药物启动后不足7天采集的拭子特异度98.6%、NPV 98.6%。
  • 抗菌药物启动后至少7天采集的拭子特异度98.7%、NPV 86.4%。

临床怎么用

  • 作者认为,抗菌药物启动后不足7天采集的阴性MRSA鼻腔拭子可用于临床稳定的疑似肺炎烧伤患者降阶梯抗MRSA治疗。
  • 作者认为,NPV下降提示定期重复采集拭子可能有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION/OBJECTIVE: This retrospective cohort study aimed to determine the sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) of MRSA nasal swabs for pneumonia in burn-injured intensive care unit (ICU) patients. METHODS: Patients 18 years or older admitted to the Burn ICU at a tertiary medical center from 2016 to 2021 were included if they had any burns, a pneumonia ICD-10 code, an MRSA nasal swab obtained during admission, and any respiratory cultures associated with at least five consecutive days of antibiotics. RESULTS: There were 267 occurrences of pneumonia across 136 patients. MRSA nasal swabs had an overall sensitivity of 39 %, specificity of 98.7 %, PPV of 84.2 %, and NPV of 89.9 %. MRSA nasal swabs obtained less than seven days from antibiotic initiation had a specificity of 98.6 % and NPV of 98.6 %; meanwhile, swabs obtained at least seven days from antibiotic initiation had a specificity of 98.7 % and NPV of 86.4 %. CONCLUSIONS: The high specificity and NPV indicate that negative MRSA nasal swabs obtained less than seven days from antibiotic initiation may be used to de-escalate anti-MRSA antibiotics in clinically stable burn-injured patients with suspicion of pneumonia. The decrease in NPV suggests that it may be beneficial to obtain a repeat swab periodically.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Carlson Z, Stoianovici R, Young S, et al. Predictive values of methicillin-resistant Staphylococcus aureus nasal swabs for pneumonia in burn ICU patients. Burns. 2024. PMID: 39317534. doi:10.1016/j.burns.2024.08.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。